GlassScriptPhysician profile
Jon A Ferlmann
NPI 1669001046
$650.84
in general payments reported to CMS, 2019-2025
16 companies · $88.28 in 2025
The $88.28 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.77 · 2022: $160 · 2023: $259 · 2024: $110 · 2025: $88.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $457.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $171.65 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Exact Sciences Corporation | $74.38 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bioventus LLC | $64.86 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.49 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $50.24 | 2022-2023 | |
| Amgen INC. | $37.39 | 2022 | |
| Sobi, INC | $24.78 | 2023 | |
| Merck Sharp & Dohme LLC | $24.38 | 2023 | Vaxneuvance, Proquad, Gardasil 9 |
| Glaxosmithkline, LLC. | $23.15 | 2024 | Arexvy, Shingrix |
| Abbvie INC. | $22.29 | 2023 | |
| Janssen Pharmaceuticals, INC | $19.14 | 2023 | Spravato |
| Astellas Pharma US INC | $18.30 | 2023 | Veozah |
| Dexcom, INC. | $16.63 | 2024 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.39 | 2021 | |
| Idorsia Pharmaceuticals US INC | $15.63 | 2023 | Quviviq |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $14.14 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Ferlmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.